Phytochemical screening and anticancer profiling of Artocarpus altilis (Breadfruit) leaves against colorectal cancer

Year 2026, Volume: 30 Issue: 1, 94 - 105, 11.01.2026

Pattilthodika Suhail , Hanmant Vatre Ashwini Kiliyamannil Asna Kausthubham Bagyasree Arunachalam Thanga Thirupathi Jibin Joy

https://doi.org/10.12991/jrespharm.1658438

https://izlik.org/JA46CE78MW

Abstract

Artocarpus altilis (A. altilis), a member of Moraceae family is a tropical tree, typically cultivated for its edible fruit. The study aimed to investigate the phytochemical composition and evaluation of in silico and in vitro anticancer activity of ethanolic extract of A. altilis leaves. LC-MS analysis was conducted to identify the presence of bioactive compounds, whereas a molecular docking study was used to find out the interaction between the phytochemicals and the DNA-metabolising enzyme topoisomerase II. MTT assay was used to assess the cytotoxicity and anticancer efficacy of the extract using HCT-116 cell lines. Through phytochemical analysis, various phytochemicals, which are known for their anticancer properties such as aminopterin, purpurin and oleuropein were identified. The molecular docking analysis revealed that the compounds, aminopterin and purpurin possess greater binding affinity with topoisomerase II, which is crucial for DNA replication and cell division in cancer cells. In MTT assay, the extract at various doses exhibited cytotoxic effects on HCT-116 cancer cell line, with an IC50 value of 153.8±0.58 µg/ml. The study reveals that the phytoconstituents of the ethanolic extract of A. altilis leaves inhibit cancer cell proliferation and their potential for use in colorectal cancer treatment.

Keywords

Anticancer activity , Artocarpus altilis , HCT-116 , molecular docking , MTT assay , Q-TOF LC-MS analysis

References

• [1] Wéber A, Vignat J, Shah R, Morgan E, Laversanne M, Nagy P, Kenessey I, Znaor A. Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World J Urol. 2024; 42(1): 237. https://doi.org/10.1007/s00345-024-04949-8
• [2] Mutiyani N, Ardaning N. Anticancer potential of ethanolic extract Artocarpus heterophyllus Lam. leaves against human colon cancer WiDr Cell Line. Biol Med Nat Prod Chem. 2024; 13(1): 221-226. https://doi.org/10.14421/biomedich.2024.131.221-226.
• [3] Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021; 14(10): 101174. https://doi.org/10.1016/j.tranon.2021.101174
• [4] Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi RE, Corcione F. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016; 68: 7-11. https://doi.org/10.1007/s13304-016-0359-y
• [5] Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi DJ, John A, Lim YC, Kibria KK, Mohiuddin AK, Ming LC, Goh KW. Colorectal cancer: A review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers. 2022; 14(7): 1732. https://doi.org/10.3390/cancers14071732
• [6] Hendricks A, Gieseler F, Nazzal S, Bräsen JH, Lucius R, Sipos B, Claasen JH, Becker T, Hinz S, Burmeister G, Schafmayer C. Prognostic relevance of topoisomerase II α and minichromosome maintenance protein 6 expression in colorectal cancer. BMC Cancer. 2019; 19: 429. https://doi.org/10.1186/s12885-019-5631-3
• [7] Gao XH, Yu ZQ, Zhang C, Bai CG, Zheng JM, Fu CG. DNA topoisomerase II alpha: a favorable prognostic factor in colorectal cancer. Int J Colorectal Dis. 2012; 27: 429-435. https://doi.org/10.1007/s00384-011-1346-x [8] Suhail P, Venkatachalam VV, Balasubramanian T, Murali R, Renganathan ABL. Evaluation of anticancer activity of Annona muricata leaf targeting FGFR3 and EGFR receptors against bladder and lung cancer. J Appl Pharm Sci. 2025; 15(04): 095–101. https://dx.doi.org/10.7324/JAPS.2025.224656
• [9] Suhail P, Venkatachalam VV, Balasubramanian T, Christapher PV. A Review on the in vitro anticancer potentials of acetogenins from Annona muricata Linn. a potential inducer of Bax-Bak and Caspase-3 related pathways. Ind J Pharm Edu Res. 2024; 58(3s): s693-703. https://doi.org/10.5530/ijper.58.3s.73
• [10] Suhail P, Venkatachalam VV, Joseph S, Murali R, Renganathan AB. In vitro anticancer potential and molecular modelling study of flavanol glucoside from Graviola (Annona muricata) fruit: A potential inhibitor of antiapoptotic proteins. Lett Appl NanoBioSci. 2024; 13(4): 167. https://doi.org/10.33263/LIANBS134.167
• [11] Akanbi TO, Nazamid S, Adebowale AA. Functional and pasting properties of a tropical breadfruit (Artocarpus altilis) starch from Ile-Ife, Osun State, Nigeria. Int Food Res J. 2009; 1(6): 151.
• [12] Jagtap UB, Bapat VA. Artocarpus: A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2010; 12(9): 143-144. https://doi.org/10.1016/j.jep.2010.03.031
• [13] Sikarwar MS, Hui BJ, Subramaniam K, Valeisamy BD, Yean LK, Balaji K. A review on Artocarpus altilis (Parkinson) Fosberg (breadfruit). J Appl Pharm Sci. 2014; 4(8): 091-097.
• [14] Haryoto H, Pratiwi Widowati. Cytotoxicity of methanol leaf extract of Artocarpus altilis, Artocarpus heterophyllus, and Artocarpus camansi against MCF-7 breast cancer cells. J Nutraceut Herb Med. 2018; 1(1): 16-23. https://doi.org/10.23917/jnhm.v1i1.5737.
• [15] Wang Y, Xu K, Lin L, PanY, Zheng X. Geranyl flavonoids from the leaves of Artocarpus altilis. Phytochemistry. 2007; 68(9): 1300–1306. https://doi.org/10.1016/j.phytochem.2007.01.009
• [16] Tantengco OAG, Jacinto SD. Cytotoxic activity of crude extracts and fractions from Premnaodorata (Blanco), Artocarpus camansi (Blanco) and Gliricidiasepium (Jacq.) against selected human cancer cell lines. Asian Pac J Trop Biomed. 2015; 5(12): 1037–1041. https://doi.org/10.1016/j.apjtb.2015.09.011.
• [17] Jalal TK, Khan AA, Natto HA, Abdull Rasad MS, Arifin Kaderi M, Mohammad M, Johan MF, Omar MN, Abdul Wahab R. Identification and quantification of quercetin, a major constituent of Artocarpus altilis by targeting related genes of apoptosis and cell cycle: In vitro cytotoxic activity against human lung carcinoma cell lines. Nutr Cancer. 2019; 71(5): 792-805. https://doi.org/10.1080/01635581.2018.1516790
• [18] Jamil MM, Ganeson S, Mammam HB, Wahab RA. Artocarpus altilis extract effect on cervical cancer cells. Mater Today: Proceed. 2018; 5(7): 15559-15566. https://doi.org/10.1016/j.matpr.2018.04.163.
• [19] Morrison IJ, Zhang J, Lin J, Murray JE, Porter R, Langat MK, Sadgrove NJ, Barker J, Zhang G, Delgoda R. Potential chemopreventive, anticancer and anti-inflammatory properties of a refined artocarpin-rich wood extract of Artocarpus heterophyllus Lam. Sci Rep. 2021; 11(1): 6854. https://doi.org/10.1038/s41598-021-86040-5.
• [20] Aswathy M, Parama D, Hegde M, DR S, Lankalapalli RS, Radhakrishnan KV, Kunnumakkara AB. Natural prenylflavones from the stem bark of Artocarpus altilis: Promising anticancer agents for oral squamous cell carcinoma targeting the Akt/mTOR/STAT-3 signaling pathway. ACS Omega. 2024; 9(23): 24252-24267. https://doi.org/10.1021/acsomega.3c08376
• [21] Mai Thanh Thi Nguyen MT, Nhan Trung Nguyen NT, Khang Duy Huu Nguyen KD, Hien Thu Thi Dau HT, Hai Xuan Nguyen HX, Phu Hoang Dang PH, Tam Minh Le TM, Trong Huu Nguyen Phan TH, Anh Hai Tran AH, Bac Duy Nguyen BD, Jun Ya Ueda JY. Geranyl dihydrochalcones from Artocarpus altilis and their antiausteric activity. Planta Med. 2014; 80(2-3): 193-200. https://doi.org/10.1055/s-0033-1360181
• [22] Jeon YoonJung JY, Jung SeungNam JS, Chang HyeYoun CH, Yun Jieun YJ, Lee ChangWoo LC, Lee JoonKu LJ, Choi SangHo CS, Nash O, Han DongCho HD, Kwon ByoungMog KB. Artocarpus altilis (Parkinson) Fosberg extracts and geranyl dihydrochalcone inhibit STAT3 activity in prostate cancer DU145 cells. Phytother Res. 2015; 29(5): 749-756. https://doi.org/10.1002/ptr.5311
• [23] Ferrer I, Thurman EM. Liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) for the analysis of emerging contaminants. TrAC Trends Anal Chem. 2003; 22(10): 750-756.
• [24] Hassen I, Casabianca H, Hosni K. Biological activities of the natural antioxidant oleuropein: Exceeding the expectation–A mini-review. J Funct Foods. 2015; 18: 926-940. https://doi.org/10.1016/j.jff.2014.09.001.
• [25] Hamdi HK, Castellon R. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem Biophys Res Commun. 2005; 334(3): 769-778. https://doi.org/10.1016/j.bbrc.2005.06.161
• [26] Singh J, Hussain Y, Luqman S, Meena A. Purpurin: A natural anthraquinone with multifaceted pharmacological activities. Phytother Res. 2021; 35(5): 2418-2428. https://doi.org/10.1002/ptr.6965
• [27] Burnett AR, Thomson RH. Naturally occurring quinones. Part XV. Biogenesis of the anthraquinones in Rubia tinctorum L.(Madder). J Chem Soc C: Organic. 1968: 2437-2741.
• [28] Cuoco G, Mathe C, Archier P, El Maâtaoui M, Vieillescazes C. Cytohistological and phytochemical study of madder root extracts obtained by ultrasonic and classical extractions. Phytochem Anal. 2009; 20(6): 484-490. https://doi.org/10.1002/pca.1150
• [29] Zengin G, Degirmenci NS, Alpsoy L, Aktumsek A. Evaluation of antioxidant, enzyme inhibition, and cytotoxic activity of three anthraquinones (alizarin, purpurin, and quinizarin). Hum Exp Toxicol. 2016; 35(5): 544-553. https://doi.org/10.1177/0960327115595687
• [30] Takahashi E, Fujita KI, Kamataki T, Arimoto-Kobayashi S, Okamoto K, Negishi T. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin. Mutat Res. 2002; 508(1-2): 147-156. https://doi.org/10.1016/s0027-5107(02)00212-9 [31] Sirotnak FM, DeGraw JI, Moccio DM, Samuels LL, Goutas LJ. New folate analogs of the 10-deaza-aminopterin series Basis for structural design and biochemical and pharmacologic properties. Cancer Chemother Pharmacol. 1984; 12: 18-25. https://doi.org/10.1007/bf00255903
• [32] El Oirdi M. Harnessing the power of polyphenols: a new frontier in disease prevention and therapy. Pharmaceuticals (Basel). 2024; 17(6): 692. https://doi.org/10.3390/ph17060692.
• [33] Singh J, Hussain Y, Luqman S, Meena A. Purpurin: A natural anthraquinone with multifaceted pharmacological activities. Phytother Res. 2021; 35(5): 2418-2428. https://doi.org/10.1002/ptr.6965.
• [34] Marin GE, Neag MA, Burlacu CC, Buzoianu AD. The protective effects of nutraceutical components in methotrexate-induced toxicity models—an overview. Microorganisms. 2022; 10(10): 2053. https://doi.org/10.3390/microorganisms10102053.
• [35] Tomlinson DC, Baldo O, Harnden P, Knowles MA. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J Pathol. 2007; 213(1): 91–98. https://doi.org/10.1002/path.2207
• [36] Lee JK, Kim DB, Kim JI, Kim PY. In vitro cytotoxicity tests on cultured human skin fibroblasts to predict skin irritation potential of surfactants. Toxicol In Vitro. 2000; 14(4): 345-349. https://doi.org/10.1016/s0887-2333(00)00028-x
• [37] Ramires PA, Romito A, Cosentino F, Milella E. The influence of titania/hydroxyapatite composite coatings on in vitro osteoblasts behaviour. Biomaterials. 2001; 22(12): 1467-1474. https://doi.org/10.1016/s0142-9612(00)00269-6